iTrack™ from Nova Eye Medical | 合法醫療器材資訊網

iTrack™ ab-interno canaloplasty comprehensively treats all sites of resistance in the conventional outflow pathway, including the collector channel ostia,6-8 to ... Read More

Long-Term Effectiveness of iTrack™ MIGS Procedure to be Spotlighted at 2021 Swiss Society of Ophthalmology. Media Release General iTrack. 25 Aug, 2021 ... Read More

Mild-moderate glaucoma. The iTrack™ MIGS procedure or ab-interno canaloplasty is redefining the treatment of early moderate glaucoma. Performed via an ab ... Read More

The iTrack™ is a tissue sparing minimally invasive glaucoma surgery that achieves excellent clinical outcomes while also preserving the viability of subsequent ... Read More

At Nova Eye Medical, we are committed to the development of novel glaucoma treatment technologies that advance clinical outcomes and improve quality of life ... Read More

Based on the same principles as angioplasty, iTrack™ combines 360° catheterization and pressurized viscodilation to remove all points of blockage in the ... Read More

Australia. Nova Eye Medical Limited 107 Rundle Street, Kent Town SA 5067. [email protected]. New Zealand. Molteno Ophthalmic Limited Read More

2021年4月19日 — Nova Eye Medical is reporting the peer-reviewed publication of 24-month data for its proprietary iTrack minimally invasive glaucoma surgery ... Read More

2020年7月30日 — Performed via an ab-interno approach and utilising breakthrough microcatheter technology, the iTrack™ (Nova Eye Medical, nova-eye.com) is an ... Read More

At the heart of Nova Eye Medical is the proprietary iTrack™ technology. An atraumatic, tissue-sparing MIGS procedure, iTrack™ achieves excellent clinical ... Read More